Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma

Luca Giovanella, Marco Maffioli, Luca Ceriani, Diego De Palma, Giuseppe Spriano

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: Thyroglobulin (Tg) measurement following thyrotropin (TSH) stimulation is used in the follow-up of patients with differentiated thyroid carcinoma (DTC). However, high-sensitive assays allow accurate measurement of serum Tg even without TSH stimulation. Here, we prospectively evaluated the impact of unstimulated high-sensitive Tg measurement in early and long-term outcome of patients with DTC. Methods: One hundred and ninety five patients affected with DTC were evaluated. Six months after thyroid ablation (i.e., thyroidectomy plus radioiodine) serum Tg was measured during TSH-suppressive thyroxine (T4) treatment (onT4-Tg). Patients with undetectable onT4-Tg and negative neck ultrasound (US) were considered disease free and onT4-Tg was measured every 12 months for a mean follow-up of 6.8 (4.7-8.9) years. Patients with an increase in onT4-Tg underwent specific diagnostic work-up and appropriate treatment if necessary. Results: Four patients showed recurrence at first follow-up visit with a corresponding increase in onT4-Tg concentrations (sensitivity 100%). Three patients had false positive onT4-Tg measurement (specificity 98%) with a spontaneous decrease within 3-6 months in all cases (specificity 100%). Three of 188 patients with undetectable serum onT4-Tg at first follow-up showed recurrence later with an increase in onT4-Tg as the first (n=2) or unique (n=1) sign of relapse (sensitivity 100%). Among 185 disease-free patients in a prolonged follow-up, 12 had a transient increase in onT4-Tg (specificity 91.6%). However, a spontaneous reduction within 3-6 months occurred in all cases (specificity 100%). Conclusions: Undetectable serum onT4-Tg using a high-sensitivity immunoradiometric assay 6 months after thyroid ablation predicts low-risk of DTC recurrence. When onT4-Tg became detectable during follow-up, the evaluation of Tg slope in a 3-6 months period accurately discriminated patients with DTC recurrence from those without recurrence. This helped avoid unnecessary diagnostic or therapeutic procedures.

Original languageEnglish
Pages (from-to)1001-1004
Number of pages4
JournalClinical Chemistry and Laboratory Medicine
Volume47
Issue number8
DOIs
Publication statusPublished - Aug 1 2009

Fingerprint

Thyroglobulin
Thyroid Neoplasms
Recurrence
Ablation
Serum
Assays
Thyroid Gland
Immunoradiometric Assay
Thyroidectomy
Thyrotropin
Thyroxine

Keywords

  • Differentiated thyroid carcinoma (DTC)
  • Follow-up
  • Thyroglobulin (Tg)
  • Thyroid

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma. / Giovanella, Luca; Maffioli, Marco; Ceriani, Luca; De Palma, Diego; Spriano, Giuseppe.

In: Clinical Chemistry and Laboratory Medicine, Vol. 47, No. 8, 01.08.2009, p. 1001-1004.

Research output: Contribution to journalArticle

Giovanella, Luca ; Maffioli, Marco ; Ceriani, Luca ; De Palma, Diego ; Spriano, Giuseppe. / Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma. In: Clinical Chemistry and Laboratory Medicine. 2009 ; Vol. 47, No. 8. pp. 1001-1004.
@article{b1e15c87819843f0a5a6fcf6c17b08e6,
title = "Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma",
abstract = "Background: Thyroglobulin (Tg) measurement following thyrotropin (TSH) stimulation is used in the follow-up of patients with differentiated thyroid carcinoma (DTC). However, high-sensitive assays allow accurate measurement of serum Tg even without TSH stimulation. Here, we prospectively evaluated the impact of unstimulated high-sensitive Tg measurement in early and long-term outcome of patients with DTC. Methods: One hundred and ninety five patients affected with DTC were evaluated. Six months after thyroid ablation (i.e., thyroidectomy plus radioiodine) serum Tg was measured during TSH-suppressive thyroxine (T4) treatment (onT4-Tg). Patients with undetectable onT4-Tg and negative neck ultrasound (US) were considered disease free and onT4-Tg was measured every 12 months for a mean follow-up of 6.8 (4.7-8.9) years. Patients with an increase in onT4-Tg underwent specific diagnostic work-up and appropriate treatment if necessary. Results: Four patients showed recurrence at first follow-up visit with a corresponding increase in onT4-Tg concentrations (sensitivity 100{\%}). Three patients had false positive onT4-Tg measurement (specificity 98{\%}) with a spontaneous decrease within 3-6 months in all cases (specificity 100{\%}). Three of 188 patients with undetectable serum onT4-Tg at first follow-up showed recurrence later with an increase in onT4-Tg as the first (n=2) or unique (n=1) sign of relapse (sensitivity 100{\%}). Among 185 disease-free patients in a prolonged follow-up, 12 had a transient increase in onT4-Tg (specificity 91.6{\%}). However, a spontaneous reduction within 3-6 months occurred in all cases (specificity 100{\%}). Conclusions: Undetectable serum onT4-Tg using a high-sensitivity immunoradiometric assay 6 months after thyroid ablation predicts low-risk of DTC recurrence. When onT4-Tg became detectable during follow-up, the evaluation of Tg slope in a 3-6 months period accurately discriminated patients with DTC recurrence from those without recurrence. This helped avoid unnecessary diagnostic or therapeutic procedures.",
keywords = "Differentiated thyroid carcinoma (DTC), Follow-up, Thyroglobulin (Tg), Thyroid",
author = "Luca Giovanella and Marco Maffioli and Luca Ceriani and {De Palma}, Diego and Giuseppe Spriano",
year = "2009",
month = "8",
day = "1",
doi = "10.1515/CCLM.2009.216",
language = "English",
volume = "47",
pages = "1001--1004",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH",
number = "8",

}

TY - JOUR

T1 - Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma

AU - Giovanella, Luca

AU - Maffioli, Marco

AU - Ceriani, Luca

AU - De Palma, Diego

AU - Spriano, Giuseppe

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Background: Thyroglobulin (Tg) measurement following thyrotropin (TSH) stimulation is used in the follow-up of patients with differentiated thyroid carcinoma (DTC). However, high-sensitive assays allow accurate measurement of serum Tg even without TSH stimulation. Here, we prospectively evaluated the impact of unstimulated high-sensitive Tg measurement in early and long-term outcome of patients with DTC. Methods: One hundred and ninety five patients affected with DTC were evaluated. Six months after thyroid ablation (i.e., thyroidectomy plus radioiodine) serum Tg was measured during TSH-suppressive thyroxine (T4) treatment (onT4-Tg). Patients with undetectable onT4-Tg and negative neck ultrasound (US) were considered disease free and onT4-Tg was measured every 12 months for a mean follow-up of 6.8 (4.7-8.9) years. Patients with an increase in onT4-Tg underwent specific diagnostic work-up and appropriate treatment if necessary. Results: Four patients showed recurrence at first follow-up visit with a corresponding increase in onT4-Tg concentrations (sensitivity 100%). Three patients had false positive onT4-Tg measurement (specificity 98%) with a spontaneous decrease within 3-6 months in all cases (specificity 100%). Three of 188 patients with undetectable serum onT4-Tg at first follow-up showed recurrence later with an increase in onT4-Tg as the first (n=2) or unique (n=1) sign of relapse (sensitivity 100%). Among 185 disease-free patients in a prolonged follow-up, 12 had a transient increase in onT4-Tg (specificity 91.6%). However, a spontaneous reduction within 3-6 months occurred in all cases (specificity 100%). Conclusions: Undetectable serum onT4-Tg using a high-sensitivity immunoradiometric assay 6 months after thyroid ablation predicts low-risk of DTC recurrence. When onT4-Tg became detectable during follow-up, the evaluation of Tg slope in a 3-6 months period accurately discriminated patients with DTC recurrence from those without recurrence. This helped avoid unnecessary diagnostic or therapeutic procedures.

AB - Background: Thyroglobulin (Tg) measurement following thyrotropin (TSH) stimulation is used in the follow-up of patients with differentiated thyroid carcinoma (DTC). However, high-sensitive assays allow accurate measurement of serum Tg even without TSH stimulation. Here, we prospectively evaluated the impact of unstimulated high-sensitive Tg measurement in early and long-term outcome of patients with DTC. Methods: One hundred and ninety five patients affected with DTC were evaluated. Six months after thyroid ablation (i.e., thyroidectomy plus radioiodine) serum Tg was measured during TSH-suppressive thyroxine (T4) treatment (onT4-Tg). Patients with undetectable onT4-Tg and negative neck ultrasound (US) were considered disease free and onT4-Tg was measured every 12 months for a mean follow-up of 6.8 (4.7-8.9) years. Patients with an increase in onT4-Tg underwent specific diagnostic work-up and appropriate treatment if necessary. Results: Four patients showed recurrence at first follow-up visit with a corresponding increase in onT4-Tg concentrations (sensitivity 100%). Three patients had false positive onT4-Tg measurement (specificity 98%) with a spontaneous decrease within 3-6 months in all cases (specificity 100%). Three of 188 patients with undetectable serum onT4-Tg at first follow-up showed recurrence later with an increase in onT4-Tg as the first (n=2) or unique (n=1) sign of relapse (sensitivity 100%). Among 185 disease-free patients in a prolonged follow-up, 12 had a transient increase in onT4-Tg (specificity 91.6%). However, a spontaneous reduction within 3-6 months occurred in all cases (specificity 100%). Conclusions: Undetectable serum onT4-Tg using a high-sensitivity immunoradiometric assay 6 months after thyroid ablation predicts low-risk of DTC recurrence. When onT4-Tg became detectable during follow-up, the evaluation of Tg slope in a 3-6 months period accurately discriminated patients with DTC recurrence from those without recurrence. This helped avoid unnecessary diagnostic or therapeutic procedures.

KW - Differentiated thyroid carcinoma (DTC)

KW - Follow-up

KW - Thyroglobulin (Tg)

KW - Thyroid

UR - http://www.scopus.com/inward/record.url?scp=70349490116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349490116&partnerID=8YFLogxK

U2 - 10.1515/CCLM.2009.216

DO - 10.1515/CCLM.2009.216

M3 - Article

C2 - 19589104

AN - SCOPUS:70349490116

VL - 47

SP - 1001

EP - 1004

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 8

ER -